16 patents
Utility
Inhibitors of RORγ
9 Feb 21
Robert J. Duguid, John A. Grosso, Sergiy Krasutsky
Filed: 24 Jul 18
Utility
Inhibitors of the menin-MLL interaction
26 Jan 21
The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
Salvacion Cacatian, David A. Claremon, Chengguo Dong, Yi Fan, Lanqi Jia, Stephen D. Lotesta, Suresh B. Singh, Shankar Venkatraman, Jing Yuan, Yajun Zheng, Linghang Zhuang
Filed: 15 Sep 17
Utility
Substituted benzoimidazoles as modulators of ROR-γ
9 Nov 20
David A. Claremon, Lawrence Wayne Dillard, Yi Fan, Stephen D. Lotesta, Suresh B. Singh, Colin M. Tice, Wei Zhao, Linghang Zhuang
Filed: 2 Apr 19
Utility
Benzimidazole derivatives as modulators of ROR-gamma
9 Nov 20
David A. Claremon, Lawrence Wayne Dillard, Yi Fan, Stephen D. Lotesta, Suresh B. Singh, Colin M. Tice, Wei Zhao, Linghang Zhuang
Filed: 26 Jan 17
Utility
Dihydropyrrolopyridine Inhibitors of Ror-gamma
28 Oct 20
David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Stephen D. Lotesta, Andrew Marcus, Suresh B. Singh, Colin M. Tice, Jing Yuan, Wei Zhao, Yajun Zheng, Linghang Zhuang
Filed: 23 Jan 20
Utility
Dihydropyrrolopyridine inhibitors of ROR-gamma
19 Oct 20
David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Zhijie Liu, Stephen D. Lotesta, Andrew Marcus, Suresh B. Singh, Colin M. Tice, Jing Yuan, Wei Zhao, Yajun Zheng, Linghang Zhuang
Filed: 8 Jul 19
Utility
Inhibitors of the menin-MLL interaction
15 Jun 20
The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
Salvacion Cacatian, David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Stephen D. Lotesta, Andrew Marcus, Angel Morales-Ramos, Suresh B. Singh, Shankar Venkatraman, Jing Yuan, Yajun Zheng, Linghang Zhuang, Stephan D. Parent, Travis L. Houston
Filed: 7 Jun 17
Utility
Dihydropyrrolopyridine Inhibitors of Ror-gamma
3 Jun 20
David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Zhijie Liu, Stephen D. Lotesta, Andrew Marcus, Suresh B. Singh, Colin M. Tice, Jing Yuan, Wei Zhao, Yajun Zheng, Linghang Zhuang
Filed: 8 Jul 19
Utility
Inhibitors of Ror Gamma
27 May 20
The present disclosure relates to salts and crystalline forms of a compound having the formula (I): Also described are processes for the production of the salts and crystalline forms described herein.
Chaoyi Deng, Jun He, Bo Xu
Filed: 23 Jul 18
Utility
Purine derivatives as CD73 inhibitors for the treatment of cancer
18 May 20
Provided are novel purine nucleoside/nucleotide analogues compounds, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are inhibitors of CD73 and are useful in the treatment of cancer.
Salvacion Cacatian, David A. Claremon, Lanqi Jia, Angel Morales-Ramos, Suresh B. Singh, Shankar Venkatraman, Zhenrong Xu, Yajun Zheng
Filed: 22 Apr 15
Utility
INHIBITORS OF RORgamma
13 May 20
Robert J. Duguid, John A. Grosso, Sergiy Krasutsky
Filed: 23 Jul 18
Utility
Liver X Receptor Modulators
6 May 20
Provided herein are novel compounds and pharmaceutically acceptable salts thereof that are liver X receptor modulators.
Chengguo Dong, Yi Fan, Katerina Leftheris, Stephen D. Lotesta, Suresh B. Singh, Colin M. Tice, Wei Zhao, Yajun Zheng, Linghang Zhuang
Filed: 20 May 19
Utility
Dihydropyrrolopyridine Inhibitors of Ror-gamma
11 Mar 20
David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Stephen D. Lotesta, Andrew Marcus, Suresh B. Singh, Colin M. Tice, Jing Yuan, Wei Zhao, Linghang Zhuang
Filed: 24 Apr 19
Utility
Modulators of Ror-gamma
26 Feb 20
David A. Claremon, Lawrence Wayne Dillard, Yi Fan, Stephen D. Lotesta, Suresh B. Singh, Colin M. Tice, Wei Zhao, Linghang Zhuang
Filed: 2 Apr 19
Utility
Benzimidazole Derivatives As Modulators of Ror-gamma
20 Nov 19
David A. Claremon, Lawrence Wayne Dillard, Yi Fan, Stephen D. Lotesta, Suresh B. Singh, Colin M. Tice, Wei Zhao, Linghang Zhuang
Filed: 26 Jan 17
Utility
Modulators of Ror-gamma
23 Oct 19
David A. Claremon, Lawrence Wayne Dillard, Yi Fan, Lanqi Jia, Suresh B. Singh, Colin M. Tice, Zhenrong Xu, Jing Yuan, Linghang Zhuang
Filed: 16 Nov 16
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first